Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1349

1.

A Comparison of Dietary Protein Digestibility, Based on DIAAS Scoring, in Vegetarian and Non-Vegetarian Athletes.

Ciuris C, Lynch HM, Wharton C, Johnston CS.

Nutrients. 2019 Dec 10;11(12). pii: E3016. doi: 10.3390/nu11123016.

2.

Variants of DNA mismatch repair genes derived from 33,998 Chinese individuals with and without cancer reveal their highly ethnic-specific nature.

Zhang L, Bhaskaran SP, Huang T, Dong H, Chandratre K, Wu X, Qin Z, Wang X, Cao W, Chen T, Lynch H, Wang SM.

Eur J Cancer. 2019 Dec 9;125:12-21. doi: 10.1016/j.ejca.2019.11.004. [Epub ahead of print]

PMID:
31830689
3.

Investigation of molecular mechanisms underlying tetracycline resistance in thermophilic Campylobacter spp. suggests that previous reports of tet(A)-mediated resistance in these bacteria are premature.

Lynch C, Hawkins K, Lynch H, Egan J, Bolton D, Coffey A, Lucey B.

Gut Pathog. 2019 Nov 9;11:56. doi: 10.1186/s13099-019-0338-1. eCollection 2019.

4.

Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?

Kotsopoulos J, Gronwald J, Lubinski J, McCuaig J, Lynch HT, Neuhausen SL, Foulkes WD, Weitzel JN, Senter L, Tung N, Eng C, Karlan B, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Menopause. 2019 Oct 21. doi: 10.1097/GME.0000000000001437. [Epub ahead of print]

PMID:
31644510
5.

Academic Advocacy: Opportunities to Influence Health and Science Policy Under U.S. Lobbying Law.

Lynch HF, Bateman-House A, Rivera SM.

Acad Med. 2019 Oct 8. doi: 10.1097/ACM.0000000000003037. [Epub ahead of print]

PMID:
31599758
6.

Aerial-trained deep learning networks for surveying cetaceans from satellite imagery.

Borowicz A, Le H, Humphries G, Nehls G, Höschle C, Kosarev V, Lynch HJ.

PLoS One. 2019 Oct 1;14(10):e0212532. doi: 10.1371/journal.pone.0212532. eCollection 2019.

7.

Filthy Lucre or Fitting Offer? Understanding Worries About Payments to Research Participants.

Largent EA, Emanuel EJ, Lynch HF.

Am J Bioeth. 2019 Sep;19(9):1-4. doi: 10.1080/15265161.2019.1631076. No abstract available.

PMID:
31543034
8.

Epigenetic Regulation of Hippocampal Fosb Expression Controls Behavioral Responses to Cocaine.

Gajewski PA, Eagle AL, Williams ES, Manning CE, Lynch H, McCornack C, Maze I, Heller EA, Robison AJ.

J Neurosci. 2019 Oct 16;39(42):8305-8314. doi: 10.1523/JNEUROSCI.0800-19.2019. Epub 2019 Sep 2.

PMID:
31477569
9.

A method to estimate pre-exploitation population size.

Foley CM, Lynch HJ.

Conserv Biol. 2019 Aug 28. doi: 10.1111/cobi.13416. [Epub ahead of print]

PMID:
31460682
10.

When the "selfish herd" becomes the "frozen herd": spatial dynamics and population persistence in a colonial seabird.

McDowall PS, Lynch HJ.

Ecology. 2019 Oct;100(10):e02823. doi: 10.1002/ecy.2823. Epub 2019 Aug 14.

PMID:
31310664
11.

Implementing Regulatory Broad Consent Under the Revised Common Rule: Clarifying Key Points and the Need for Evidence.

Lynch HF, Wolf LE, Barnes M.

J Law Med Ethics. 2019 Jun;47(2):213-231. doi: 10.1177/1073110519857277.

PMID:
31298108
12.

Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome.

Hitchins MP, Vogelaar IP, Brennan K, Haraldsdottir S, Zhou N, Martin B, Alvarez R, Yuan X, Kim S, Guindi M, Hendifar AE, Kalady MF, DeVecchio J, Church JM, de la Chapelle A, Hampel H, Pearlman R, Christensen M, Snyder C, Lanspa SJ, Haile RW, Lynch HT.

BMJ Open Gastroenterol. 2019 May 28;6(1):e000299. doi: 10.1136/bmjgast-2019-000299. eCollection 2019.

13.

Using a continuum model to decipher the mechanics of embryonic tissue spreading from time-lapse image sequences: An approximate Bayesian computation approach.

Stepien TL, Lynch HE, Yancey SX, Dempsey L, Davidson LA.

PLoS One. 2019 Jun 27;14(6):e0218021. doi: 10.1371/journal.pone.0218021. eCollection 2019.

14.

Elongated Cells Drive Morphogenesis in a Surface-Wrapped Finite-Element Model of Germband Retraction.

McCleery WT, Veldhuis J, Bennett ME, Lynch HE, Ma X, Brodland GW, Hutson MS.

Biophys J. 2019 Jul 9;117(1):157-169. doi: 10.1016/j.bpj.2019.05.023. Epub 2019 Jun 5.

PMID:
31229244
15.

Paying Clinical Trial Participants: Legal Risks and Mitigation Strategies.

Largent EA, Heffernan KG, Joffe S, Lynch HF.

J Clin Oncol. 2019 Jun 14:JCO1900250. doi: 10.1200/JCO.19.00250. [Epub ahead of print] No abstract available.

PMID:
31199697
16.

Mountains and Molehills When Using Social Media as a Research Support Tool.

Lynch HF, Largent EA.

Am J Bioeth. 2019 Jun;19(6):64-66. doi: 10.1080/15265161.2019.1602190. No abstract available.

PMID:
31135319
17.

The benefits of a model of interval comprehensive assessments (MICA) in hereditary cancer Syndromes: Hereditary diffuse gastric cancer (HDGC) as an example.

Lynch HT, Nustas R, Kassim T, Snyder C, Shaw T, Diab O.

Cancer Genet. 2019 Apr;233-234:43-47. doi: 10.1016/j.cancergen.2019.03.005. Epub 2019 Mar 25.

PMID:
31109593
18.

Influence of the Intestinal Microbiota on Colonization Resistance to Salmonella and the Shedding Pattern of Naturally Exposed Pigs.

Argüello H, Estellé J, Leonard FC, Crispie F, Cotter PD, O'Sullivan O, Lynch H, Walia K, Duffy G, Lawlor PG, Gardiner GE.

mSystems. 2019 Apr 23;4(2). pii: e00021-19. doi: 10.1128/mSystems.00021-19. eCollection 2019 Mar-Apr.

19.

Ethical Review and Methodologic Innovation in Phase 1 Cancer Trials-Reply.

Kimmelman J, Waligora M, Lynch HF.

JAMA Pediatr. 2019 Jun 1;173(6):609-610. doi: 10.1001/jamapediatrics.2019.0797. No abstract available.

PMID:
31009030
20.

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.

Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Br J Cancer. 2019 Jul;121(1):15-21. doi: 10.1038/s41416-019-0446-1. Epub 2019 Apr 11.

PMID:
30971774
21.

Analysis of the CDKN2A Gene in FAMMM Syndrome Families Reveals Early Age of Onset for Additional Syndromic Cancers.

Middlebrooks CD, Stacey ML, Li Q, Snyder C, Shaw TG, Richardson-Nelson T, Rendell M, Ferguson C, Silberstein P, Casey MJ, Bailey-Wilson JE, Lynch HT.

Cancer Res. 2019 Jun 1;79(11):2992-3000. doi: 10.1158/0008-5472.CAN-18-1580. Epub 2019 Apr 9.

PMID:
30967399
22.

Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening.

Choi HW, Chan C, Shterev ID, Lynch HE, Robinette TJ, Johnson-Weaver BT, Shi J, Sempowski GD, Kim SY, Dickson JK, Gooden DM, Abraham SN, Staats HF.

SLAS Discov. 2019 Jul;24(6):628-640. doi: 10.1177/2472555219834699. Epub 2019 Mar 27.

PMID:
30917061
23.

Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Lubinski J, Lynch HT, Tung N, Armel S, Senter L, Singer CF, Fruscio R, Couch F, Weitzel JN, Karlan B, Foulkes WD, Moller P, Eisen A, Ainsworth P, Neuhausen SL, Olopade O, Sun P, Gronwald J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Breast Cancer Res Treat. 2019 Jun;175(2):443-449. doi: 10.1007/s10549-019-05162-7. Epub 2019 Feb 12.

PMID:
30756284
24.

Oestrogen receptor status and survival in women with BRCA2-associated breast cancer.

Metcalfe K, Lynch HT, Foulkes WD, Tung N, Olopade OI, Eisen A, Lerner-Ellis J, Snyder C, Kim SJ, Sun P, Narod SA.

Br J Cancer. 2019 Feb;120(4):398-403. doi: 10.1038/s41416-019-0376-y. Epub 2019 Feb 6.

PMID:
30723304
25.

Patient-Centered Outcomes Research: Stakeholder Perspectives and Ethical and Regulatory Oversight Issues.

Largent EA, Weissman JS, Gupta A, Abraham M, Rozenblum R, Lynch HF, Cohen IG.

IRB. 2018 Jan-Feb;40(1):7-17. No abstract available.

26.

Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers.

Downs B, Sherman S, Cui J, Kim YC, Snyder C, Christensen M, Luo J, Lynch H, Wang SM.

Eur J Cancer. 2019 Jan;107:68-78. doi: 10.1016/j.ejca.2018.10.022. Epub 2018 Dec 11.

PMID:
30551077
27.

Of Parachutes and Participant Protection: Moving Beyond Quality to Advance Effective Research Ethics Oversight.

Lynch HF, Nicholls S, Meyer MN, Taylor HA; Consortium to Advance Effective Research Ethics Oversight (AEREO).

J Empir Res Hum Res Ethics. 2019 Jul;14(3):190-196. doi: 10.1177/1556264618812625. Epub 2018 Dec 12.

PMID:
30541368
28.

Plant-Based Diets: Considerations for Environmental Impact, Protein Quality, and Exercise Performance.

Lynch H, Johnston C, Wharton C.

Nutrients. 2018 Dec 1;10(12). pii: E1841. doi: 10.3390/nu10121841. Review.

29.

Evidence-based practice education for healthcare professions: an expert view.

Lehane E, Leahy-Warren P, O'Riordan C, Savage E, Drennan J, O'Tuathaigh C, O'Connor M, Corrigan M, Burke F, Hayes M, Lynch H, Sahm L, Heffernan E, O'Keeffe E, Blake C, Horgan F, Hegarty J.

BMJ Evid Based Med. 2019 Jun;24(3):103-108. doi: 10.1136/bmjebm-2018-111019. Epub 2018 Nov 15.

30.

Participant Protection in Phase 1 Pediatric Cancer Trials.

Kimmelman J, Waligora M, Lynch HF.

JAMA Pediatr. 2019 Jan 1;173(1):8-9. doi: 10.1001/jamapediatrics.2018.3629. No abstract available.

PMID:
30419141
31.

Protecting clinical trial participants and study integrity in the age of social media.

Lynch HF, Largent EA, Joffe S, DeMichele AM.

Cancer. 2018 Dec 15;124(24):4610-4617. doi: 10.1002/cncr.31748. Epub 2018 Oct 17. No abstract available.

32.

Patient-Engaged Research: Choosing the "Right" Patients to Avoid Pitfalls.

Largent EA, Lynch HF, McCoy MS.

Hastings Cent Rep. 2018 Sep;48(5):26-34. doi: 10.1002/hast.898.

PMID:
30311207
33.

Impact of early life exposure to ionizing radiation on influenza vaccine response in an elderly Japanese cohort.

Hayashi T, Lynch HE, Geyer S, Yoshida K, Furudoi K, Sasaki K, Morishita Y, Nagamura H, Maki M, Hu Y, Hayashi I, Kyoizumi S, Kusunoki Y, Ohishi W, Fujiwara S, Misumi M, Shterev I, Nikolich-Žugich J, Murasko D, Hale LP, Sempowski GD, Nakachi K.

Vaccine. 2018 Oct 29;36(45):6650-6659. doi: 10.1016/j.vaccine.2018.09.054. Epub 2018 Sep 28.

PMID:
30274868
34.

Oversight of Patient-Centered Outcomes Research: Recommendations From a Delphi Panel.

Gelinas L, Weissman JS, Lynch HF, Gupta A, Rozenblum R, Largent EA, Cohen IG; Delphi Working Group Participants.

Ann Intern Med. 2018 Oct 16;169(8):559-563. doi: 10.7326/M18-1334. Epub 2018 Sep 25.

PMID:
30264127
35.

Promoting Patient Interests in Implementing the Federal Right to Try Act.

Lynch HF, Zettler PJ, Sarpatwari A.

JAMA. 2018 Sep 4;320(9):869-870. doi: 10.1001/jama.2018.9880. No abstract available.

PMID:
30105394
36.

Letter to the editor re: Guyton et al. (2018), 'Application of the key characteristics of carcinogens in cancer hazard identification'.

Goodman JE, Lynch HN, Rhomberg LR.

Carcinogenesis. 2018 Jul 30;39(8):1089-1090. doi: 10.1093/carcin/bgy066. No abstract available.

PMID:
29982454
37.

Critique of the ACGIH 2016 derivation of toluene diisocyanate Threshold Limit Values.

Lynch HN, Prueitt RL, Goodman JE.

Regul Toxicol Pharmacol. 2018 Aug;97:189-196. doi: 10.1016/j.yrtph.2018.06.017. Epub 2018 Jun 28. Review.

38.

Response-Evaluating human trials: FDA's role.

Shah SK, Kimmelman J, Lyerly AD, Lynch HF, Miller FG, Palacios R, Pardo CA, Zorrilla C.

Science. 2018 Jun 22;360(6395):1308-1309. doi: 10.1126/science.aau0865. Epub 2018 Jun 21. No abstract available.

PMID:
29930129
39.

IRB Oversight of Patient-Centered Outcomes Research: A National Survey of IRB Chairpersons.

Weissman JS, Campbell EG, Cohen IG, Lynch HF, Largent EA, Gupta A, Rozenblum R, Abraham M, Spikes K, Fagan M, Carnie M.

J Empir Res Hum Res Ethics. 2018 Oct;13(4):421-431. doi: 10.1177/1556264618779785. Epub 2018 Jun 14.

40.

Reaping the Bounty of Publicly Available Clinical Trial Consent Forms.

Lynch HF, Largent EA, Zarin DA.

IRB. 2017 Nov-Dec;39(6):10-15.

41.

Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.

Kotsopoulos J, Gronwald J, Karlan B, Rosen B, Huzarski T, Moller P, Lynch HT, Singer CF, Senter L, Neuhausen SL, Tung N, Eisen A, Foulkes WD, Ainsworth P, Sun P, Lubinski J, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.

Gynecol Oncol. 2018 Jul;150(1):85-91. doi: 10.1016/j.ygyno.2018.05.011. Epub 2018 May 21.

PMID:
29793803
42.

Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Kotsopoulos J, Gronwald J, Lynch HT, Eisen A, Neuhausen SL, Tung N, Ainsworth P, Weitzel JN, Pal T, Foulkes WD, Eng C, Singer CF, Senter L, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Breast Cancer Res Treat. 2018 Sep;171(2):421-426. doi: 10.1007/s10549-018-4822-y. Epub 2018 May 17.

PMID:
29774471
43.

No Difference Between the Effects of Supplementing With Soy Protein Versus Animal Protein on Gains in Muscle Mass and Strength in Response to Resistance Exercise.

Messina M, Lynch H, Dickinson JM, Reed KE.

Int J Sport Nutr Exerc Metab. 2018 Nov 1;28(6):674-685. doi: 10.1123/ijsnem.2018-0071. Epub 2018 Oct 26.

PMID:
29722584
44.

Truth in Advertising: Disclosure of Participant Payment in Research Recruitment Materials.

Gelinas L, Lynch HF, Largent EA, Shachar C, Cohen IG, Bierer BE.

Ther Innov Regul Sci. 2018 May;52(3):268-274. doi: 10.1177/2168479018770644. Epub 2018 Apr 8.

PMID:
29714586
45.

Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.

Kotsopoulos J, Gronwald J, Karlan BY, Huzarski T, Tung N, Moller P, Armel S, Lynch HT, Senter L, Eisen A, Singer CF, Foulkes WD, Jacobson MR, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

JAMA Oncol. 2018 Aug 1;4(8):1059-1065. doi: 10.1001/jamaoncol.2018.0211. Erratum in: JAMA Oncol. 2018 Aug 1;4(8):1139.

46.

Addressing Financial Barriers to Enrollment in Clinical Trials.

Largent EA, Lynch HF.

JAMA Oncol. 2018 Jul 1;4(7):913-914. doi: 10.1001/jamaoncol.2018.0492. No abstract available.

PMID:
29710211
47.

Bystander risk, social value, and ethics of human research.

Shah SK, Kimmelman J, Lyerly AD, Lynch HF, Miller FG, Palacios R, Pardo CA, Zorrilla C.

Science. 2018 Apr 13;360(6385):158-159. doi: 10.1126/science.aaq0917. Epub 2018 Apr 12. No abstract available.

PMID:
29650663
48.

On Scarcity and the Value of Clinical Trials.

Gelinas L, Lynch HF, Bierer BE, Cohen IG.

Am J Bioeth. 2018 Apr;18(4):71-73. doi: 10.1080/15265161.2018.1444819. No abstract available.

PMID:
29621470
49.

Mutual Obligations in Research and Withholding Payment From Deceptive Participants.

Lynch HF, Gelinas L, Largent EA.

Am J Bioeth. 2018 Apr;18(4):85-87. doi: 10.1080/15265161.2018.1431703. No abstract available.

PMID:
29621447
50.

Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma.

Wei X, Calvo-Vidal MN, Chen S, Wu G, Revuelta MV, Sun J, Zhang J, Walsh MF, Nichols KE, Joseph V, Snyder C, Vachon CM, McKay JD, Wang SP, Jayabalan DS, Jacobs LM, Becirovic D, Waller RG, Artomov M, Viale A, Patel J, Phillip J, Chen-Kiang S, Curtin K, Salama M, Atanackovic D, Niesvizky R, Landgren O, Slager SL, Godley LA, Churpek J, Garber JE, Anderson KC, Daly MJ, Roeder RG, Dumontet C, Lynch HT, Mullighan CG, Camp NJ, Offit K, Klein RJ, Yu H, Cerchietti L, Lipkin SM.

Cancer Res. 2018 May 15;78(10):2747-2759. doi: 10.1158/0008-5472.CAN-17-1900. Epub 2018 Mar 20.

Supplemental Content

Support Center